FT US Healthcare And Life Sciences

The healthcare and life sciences industry are facing a time of both tumultuous change and momentous opportunity. In the US, healthcare reform has reached a new level of maturity and is beginning to transform the landscape of the industry for payers, providers and patients; The biotechnology industry is on the rise, and has been leading the way in deal making and important drug launches.